Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2020
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
drug discovery
mitochondrial diseases |
| gptkbp:foundedIn |
2014
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Nanna Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:bfsLayer |
7
|